Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis.
about
Hepatocellular Carcinoma: Risk Factors, Diagnosis and TreatmentSilencing Viral MicroRNA as a Novel Antiviral Therapy?Most common genotypes and risk factors for HCV in Gaza strip: a cross sectional studyFrom hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanismsHepitopes: A live interactive database of HLA class I epitopes in hepatitis B virusScreening serum biomarkers for early primary hepatocellular carcinoma using a phage display technique.Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis.First multicenter study for risk factors for hepatocellular carcinoma development in North Africa.The protective role of ellagitannins flavonoids pretreatment against N-nitrosodiethylamine induced-hepatocellular carcinoma.Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci in a Chinese population.LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy.Hepatitis C Virus Protein Interaction Network Analysis Based on Hepatocellular CarcinomaEpigenetic mechanisms in virus-induced tumorigenesis.Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers.Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategiesImmunotherapeutic approaches to hepatocellular carcinoma treatmentViral manipulation of DNA repair and cell cycle checkpointsViral hepatitis status does not affect survival in patients with hepatocellular carcinoma.Viral epigenomes in human tumorigenesis.IL-22: a promising candidate to inhibit viral-induced liver disease progression and hepatocellular carcinoma.Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalitiesRegulation of the microRNA processor DGCR8 by hepatitis B virus proteins via the transcription factor YY1.Expression and clinical implications of HAb18G/CD147 in hepatocellular carcinoma.Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report.Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells.Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack.The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.Exploiting bilosomes for delivering bioactive polysaccharide isolated from Enteromorpha intestinalis for hacking hepatocellular carcinoma.Hepatocellular carcinoma: clinical and radiological findings in patients with chronic B viral hepatitis and chronic C viral hepatitis.Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure.Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues
P2860
Q26747551-5155719A-F09F-4093-8075-A62B692A717EQ27488437-46C26ABD-C97C-401A-BAE8-106B8EB8B382Q27489005-6AAC30D0-32E8-470D-AC8D-8B74464D0516Q28383729-91219A8C-0C15-4449-AC6D-E2B5468C189EQ28588907-F40E69D1-7052-495A-AAEB-A8B3C527FA54Q34075313-A31FD7DB-9CBF-4776-8D1A-658FC778295AQ34365396-F27607D2-4572-4164-98F2-B7E980FA62DCQ34560817-9D376A77-A7B0-4309-9669-A7CAB9E02995Q34604085-62513BC9-EF1E-4F10-873F-C46156F8EB96Q35035182-7D472BC3-7253-4EE0-8854-5444F0C28329Q35793672-12B6D060-DCDA-461F-BC70-DDE1ADC42946Q35999440-0095BD5A-45DD-4D2B-9E29-C3693A11213BQ36001887-BD8EE53A-3EA0-499F-8A81-B2B59CA2EB56Q36171138-EF7FF69F-7C80-4DEE-A154-68FD0C1D3825Q36561567-C88D4CBD-2758-43BF-8EA6-D89DE9C10D0DQ37140685-0741CFF7-7A2B-416B-9076-26BAB27FA562Q37301053-3E454544-2283-4E08-B90A-9CCB50561C50Q37542814-49F8DCB8-3148-42E3-9932-B3AF421796AEQ37681282-7FEB7E5B-D642-4D49-8618-D2D30B7721C9Q38626350-4B762302-38B6-4CAE-A5EC-39B121739690Q38935703-36C12B10-9B5C-4170-858E-C21B53A7C7BCQ38937494-0DEECDD4-6FAA-406E-BA70-9BA3BC05E63BQ39018781-98359629-CA22-44DF-A5D1-85D4143D8825Q41826080-18976656-F831-4CA1-BF45-123E626B73A8Q44652572-A24A4DE5-312D-465F-A495-E14C5C495E9DQ45365788-B57378D3-1C49-460D-9A91-923BC33D1826Q46825794-F6DAAD5C-3F5B-4391-8090-AA0D92429EF0Q47426135-52F5CF36-CBF9-4F4A-8AB7-E040EF0C21B5Q53406935-C827B86B-9EEA-4859-9ED7-884B0A9E0E11Q54231589-BD4FE700-3373-4F74-86E9-5955B728BC62Q58774311-E868C3C4-F512-49A5-A094-B1460E9ECE47
P2860
Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human oncogenic viruses: hepat ...... role in hepatocarcinogenesis.
@en
Human oncogenic viruses: hepat ...... role in hepatocarcinogenesis.
@nl
type
label
Human oncogenic viruses: hepat ...... role in hepatocarcinogenesis.
@en
Human oncogenic viruses: hepat ...... role in hepatocarcinogenesis.
@nl
prefLabel
Human oncogenic viruses: hepat ...... role in hepatocarcinogenesis.
@en
Human oncogenic viruses: hepat ...... role in hepatocarcinogenesis.
@nl
P1433
P1476
Human oncogenic viruses: hepat ...... r role in hepatocarcinogenesis
@en
P2093
Gurtsevitch VE
P2888
P304
P356
10.1134/S0006297908050039
P577
2008-05-01T00:00:00Z
P6179
1034654388